Efficacy Studies Not Enough? Consider GSK's Salford Lung Study As New Model

Full results from asthma patients included in the Salford Lung Study provide powerful support for the use of “real world” effectiveness studies as a more relevant form of evidence to inform prescribing choices and improve patient outcomes, particularly in what turned out to be a general population of asthmatics that were still suffering symptoms under usual care.

Door
Clean air is important to asthmatics; real world evidence may change clinical practice • Source: Shutterstock.

The full results of the asthma part of the GlaxoSmithKline PLC’s Salford Lung Study have confirmed the beneficial effects of the once-daily inhaler combination Relvar Ellipta (fluticasone furoate/vilanterol, known as Breo Ellipta in the US) on asthma symptoms compared with usual care, in a “real-world” clinical effectiveness study that calls into question the dominance of double-blind randomized efficacy studies in supporting clinical guidelines and prescribing decisions that drive medicines’ market share and, ultimately, company profits.

The lead investigator for the Salford Lung Study, Ashley Woodcock, professor of respiratory medicine at the University of Manchester, has...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

EU Sees Unified Pathway For Drug/IVD Studies As Key To Future Research Investment

 
• By 

As the EU tests the feasibility of a radical “all-in-one” procedure for combined drug and IVD studies, sponsors are being urged to approach this novel framework with flexibility and openness.

Woodcock: Do Not Do The Wrong Study, Even If Against US FDA Advice

 

The former CDER director said she tells sponsors not to conduct an FDA-recommended study design or randomized trial if it will not work.

AI Will Bolster, Not Squelch, Patient Voice In Clinical Research, US FDA Says

 
• By 

Artificial intelligence tools used for clinical research should be developed with input from patients and focus on their needs and abilities, FDA experts said.

UK Looks To Auto-Match NHS Patients With Clinical Trials To Boost Recruitment

 
• By 

The UK government is making it easier for millions of people to participate in clinical trials and is boosting transparency around how studies are delivered across the National Health Service.

More from R&D